Literature DB >> 1637682

Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines.

D J Bernard1, F Courjal, J C Maurizis, Y J Bignon, P Chollet, R Plagne.   

Abstract

The spontaneous expression of HLA class I and class II molecules in two human breast carcinoma cell lines (MCF7, T47D) and their modulation during epidermal growth factor treatment are reported. Transcription was analysed by Northern blot and hybridisation with HLA class II and class I cDNA specific probes. The expression of cell surface determinants was examined by internal protein labelling with 35s-methionine, immunoprecipitation with monoclonal antibodies specific for HLA class I or class II, followed by isolation of the immune complex on protein A-Sepharose; at least a quantification of glycoprotein was performed by chromatofocusing. Glycoprotein quantification showed a significant increase of HLA class I and class II (DR) antigen expression after stimulation by epidermal growth factor (0.02 microgram ml-1) in the two cell lines, when compared with untreated cell controls. However, with epidermal growth factor treatment of MCF7 and T47D cells, low increases in the amounts of HLA class I and class II RNA were obtained. These differences between expressed antigens and correspondent RNA amounts would be explained by the fact that EGF in these two cell lines acts more in post-transcription for HLA class I and class II antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637682      PMCID: PMC1977879          DOI: 10.1038/bjc.1992.222

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  HLA-A,B antigens Ia-like antigens, and tumor-associated antigens on prostate carcinoma cell lines: serologic and immunochemical analysis with monoclonal antibodies.

Authors:  A K Ng; M A Pellegrino; K Imai; S Ferrone
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

2.  Isolation of cDNA clones encoding HLA-DR alpha chains.

Authors:  C T Wake; E O Long; M Strubin; N Gross; R Accolla; S Carrel; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain.

Authors:  C Auffray; A J Korman; M Roux-Dosseto; R Bono; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

4.  Changes in Ia-like antigen expression on malignant human cells.

Authors:  P G Natali; C De Martino; V Quaranta; A Bigotti; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  The presence of HLA-DR antigens on lactating human breast epithelium and milk fat globule membranes.

Authors:  R A Newman; M G Ormerod; M F Greaves
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

6.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

7.  Hormonal regulation of the expression of Ia antigens on mammary gland epithelium.

Authors:  L Klareskog; U Forsum; P A Peterson
Journal:  Eur J Immunol       Date:  1980-12       Impact factor: 5.532

8.  Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies.

Authors:  A J Howe; R C Seeger; G A Molinaro; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  3 in total

1.  HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.

Authors:  M Feinmesser; A Sulkes; S Morgenstern; J Sulkes; S Stern; E Okon
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

2.  Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.

Authors:  Baowei Ji; Qianxue Chen; Baohui Liu; Liquan Wu; Daofeng Tian; Zhentao Guo; Wei Yi
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

3.  LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A.

Authors:  Wei Zhou; Shilin Xu; Tingfen Deng; Ruiqing Zhou; Caixia Wang
Journal:  Hum Cell       Date:  2021-10-25       Impact factor: 4.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.